Cargando…
What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics
Although the past few decades have shown an improvement in the survival and complication-free survival rates in patients with beta-thalassemia major and gene therapy is already at an advanced stage of experimentation, hematopoietic stem cell transplantation (HSCT) continues to be the only effective...
Autores principales: | La Nasa, Giorgio, Vacca, Adriana, Littera, Roberto, Piras, Eugenia, Orru, Sandro, Greco, Marianna, Carcassi, Carlo, Caocci, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111522/ https://www.ncbi.nlm.nih.gov/pubmed/27872728 http://dx.doi.org/10.4084/MJHID.2016.048 |
Ejemplares similares
-
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
por: Caocci, Giovanni, et al.
Publicado: (2011) -
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia
por: Orrù, Sandro, et al.
Publicado: (2012) -
Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
por: Pisu, Salvatore, et al.
Publicado: (2014) -
Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
por: Sanna, Marco, et al.
Publicado: (2013) -
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation
por: Mulas, Olga, et al.
Publicado: (2023)